Warning: The NCBI web site requires JavaScript to function. more...
Dendritic cell defects in patients with cancer: mechanisms and significance.
Lenahan C, Avigan D.
Breast Cancer Res. 2006;8(1):101. Epub 2006 Jan 5.
Related citations
Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
Pinzon-Charry A, Maxwell T, McGuckin MA, Schmidt C, Furnival C, López JA.
Breast Cancer Res. 2006;8(1):R5. Epub 2005 Dec 16.
Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
Cell Immunol. 2009;257(1-2):23-31.
The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction.
Pinzon-Charry A, Schmidt CW, López JA.
Breast Cancer Res. 2006;8(1):402. Epub 2006 Feb 22.
Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
Oncol Rep. 2006 Dec;16(6):1317-24.
Tumour antigen-loaded mouse dendritic cells maturing in the presence of inflammatory cytokines are potent activators of immune response in vitro but not in vivo.
Rossowska J, Pajtasz-Piasecka E, Szyda A, Krawczenko A, Zietara N, Dus D.
Oncol Rep. 2009 Jun;21(6):1539-49.
Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer.
Pinzon-Charry A, Ho CS, Maxwell T, McGuckin MA, Schmidt C, Furnival C, Pyke CM, López JA.
Br J Cancer. 2007 Nov 5;97(9):1251-9. Epub 2007 Oct 9.
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, Sauerbruch T, Schmitz V.
Hepatology. 2008 Jul;48(1):157-68.
An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells.
He XZ, Wang L, Zhang YY.
World J Gastroenterol. 2008 Jan 28;14(4):532-40.
Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.
Mimura K, Kono K, Takahashi A, Kawaguchi Y, Fujii H.
Cancer Immunol Immunother. 2007 Jun;56(6):761-70. Epub 2006 Nov 4.
Dendritic cell-based therapeutics for breast cancer.
Pilon-Thomas SA, Verhaegen ME, Mulé JJ.
Breast Dis. 2004;20:65-71. Review.
[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
Tan G, Wang ZY, Yin S.
Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):943-6. Chinese.
Virology- and immunology-based gene therapy for cancer.
Tagawa M, Kawamura K, Shimozato O, Ma G, Li Q, Suzuki N, Shimada H, Ochiai T.
Cancer Immunol Immunother. 2006 Nov;55(11):1420-5. Epub 2006 May 12. Review.
Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J, Jacobs P, Doffek K, Sugg SL.
J Pediatr Surg. 2007 Jan;42(1):54-61; discussion 61.
Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H.
Int J Oncol. 2006 Jun;28(6):1481-9.
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z, Huang XL, Kalinski P, Young S, Rinaldo CR Jr.
Clin Vaccine Immunol. 2007 Sep;14(9):1127-37. Epub 2007 Jul 18.
Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
Zhang Y, Ma B, Zhou Y, Zhang M, Qiu X, Sui Y, Zhang X, Ma B, Fan Q.
Breast Cancer Res Treat. 2007 Nov;105(3):277-86. Epub 2006 Dec 23.
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer.
Milano F, Rygiel AM, Buttar N, Bergman JJ, Sondermeijer C, van Baal JW, ten Brinke A, Kapsenberg M, van Ham SM, Peppelenbosch MP, Krishnadath KK.
Cancer Immunol Immunother. 2007 Dec;56(12):1967-77. Epub 2007 Jun 13.
Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.
Oncol Rep. 2007 Apr;17(4):895-902.
Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.
Int J Oncol. 2007 Jun;30(6):1461-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on